<DOC>
	<DOCNO>NCT03023345</DOCNO>
	<brief_summary>The purpose study determine trans-rectal microwave ablation index tumor patient low-risk prostate cancer sufficiently precise safe , use MRI-transrectal ultrasound image registration .</brief_summary>
	<brief_title>Trans-rectal Focal Microwave Ablation Index Tumor Patients With Low-risk Prostate Cancer</brief_title>
	<detailed_description>In men low-risk prostate cancer , European American guideline recommend either active surveillance whole-gland treatment , significant induced morbidity burden quality life . Focal treatment index tumor currently investigation decrease morbidity propose active treatment . The purpose study determine feasibility , precision safety novel ablation treatment use microwave , deliver transrectally real-time guidance MRI-transrectal ultrasound image registration . The index tumor detect prostate MRI characterize targeted biopsy use MRI-transrectal ultrasound image registration . It ablate microwave use transrectal approach guidance system ( KOELIS ) .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients age 45 76 year old ; Life expectancy 10 year ; Diagnosis prostate cancer confirm prostate biopsy ; Low risk progression , define D'Amico criterion : T1c T2a stage Maximum Gleason score 3+3 , include target biopsy Prostate Specific Antigen &lt; 10 ng/mL Detection index tumor prostate MRI , characterize targeted biopsy use MRItransrectal ultrasound image registration ; Patient accept follow procedure use active surveillance protocol standard ; Patient affiliate national health care insurance ; Free consent , inform write , date sign patient investigator enrollment . Medical past history prostatic surgery ; Medical past history radiotherapy pelvic trauma ; Medical past history acute chronic prostatitis severe BPHrelated urinary tract symptom define IPSS &gt; 18 ; Extracapsular extension seminal vesicle invasion prostate MRI . Tumor involvement &gt; 3 mm systematic biopsy outside tumor volume detect MRI . Tumor large axis &gt; 20 mm prostate MRI ; Distance le 5 mm tumor rectum Patient unable understand course study</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>cancer</keyword>
	<keyword>prostate</keyword>
	<keyword>PSA</keyword>
	<keyword>biopsy</keyword>
	<keyword>microwave trans rectal focal treatment</keyword>
</DOC>